Get started
Author

Uma Mylavarapu

Observed names: Mylavarapu Uma, U Mylavarapu, UMA MYLAVARAPU
OpenAlex ID: A5076852579
Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction
2025 · Yoran Crum, Dirk J. van Veldhuisen, et al. · JACC Advances · 9
Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction
2025 · Barry A. Borlaug, Julio A. Chirinos, et al. · JACC Heart Failure · 6
Refining Atrial Shunt Therapy for Heart Failure With Preserved Ejection Fraction: Lessons From Pivotal Randomized Trials and Emerging Directions
2025 · DYLAN J. GYBERG, JAN KOMTEBEDDE, et al. · Journal of Cardiac Failure · 1
B-po04-013 Periostin as a Marker of Fibrotic Substrate for Reentrant Atrial Fibrillation Drivers in Human Hearts
2021 · Ning Li, Esthela Artiga, et al. · Heart Rhythm · 1
Type 2 diabetes in heart failure with preserved and mildly reduced ejection fraction: insights from the REDUCE-LAP-HF II trial
2026 · Misha Dagan, Shane Nanayakkara, et al. · ESC Heart Failure
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF
2026 · Shunichi Doi, Sho Kazui, et al. · JACC Heart Failure
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF II
2026 · Andrew A. Girard, Uma Mylavarapu, et al. · Circulation Population Health and Outcomes
PDF
Epicardial adipose tissue, functional status, and invasive exercise hemodynamics in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial
2025 · Y Crum, D J Van Veldhuisen, et al. · European Heart Journal
PDF
Estimating the Placebo Effect of Patient-reported Outcomes in Sham-controlled Device Trials: a Secondary Analysis of the Reduce Lap-hf Ii Study
2025 · Andrew Girard, Uma Mylavarapu, et al. · Journal of the American College of Cardiology
PDF
Atrial Shunting Protects Against Longitudinal Worsening of Right Ventricular Free Wall Strain in Hfpef/hfmref: Findings From Reduce-lap Hf
2025 · Bong-Joon Kim, Sheldon E. Litwin, et al. · Journal of the American College of Cardiology
PDF
Abstract 15179: Histology-Validated Delayed Enhancement Magnetic Resonance Imaging of Atrial Fibrillation Driver Substrate
2022 · Uma Mylavarapu, Benjamin Buck, et al. · Circulation
Po-646-08 Heterogeneous Transmural Fibrosis Remodeling Creates Arrhythmogenic Substrates in a Canine Model of Persistent Atrial Fibrillation
2022 · Anuradha Kalyanasundaram, Uma Mylavarapu, et al. · Heart Rhythm
B-po05-017 in Vivo to Ex Vivo High Resolution Optical Mapping and Contrast Enhanced Magnetic Resonance Imaging to Reveal Atrial Fibrillation Drivers and Improve Identification of Arrhythmogenic Structural Substrates in Persistent Atrial Fibrillation Canine Model
2021 · Aleksei Mikhailov, Megan Subr, et al. · Heart Rhythm
B-po02-017 Mapping Molecular Fibrotic Signatures of Disease-specific Right and Left Atrial Substrates of Atrial Fibrillation in Human Hearts With and Without Heart Failure
2021 · Anuradha Kalyanasundaram, Ning Li, et al. · Heart Rhythm
Abstract 15311: Drivers Associated With Dense Fibrotic Regions Are Critical Targets in Extra-Pulmonary Vein Ablation in Persistent Atrial Fibrillation
2020 · Megan M Subr, Uma Mylavarapu, et al. · Circulation
Abstract 14897: Activation Dyssynchrony Between Contact Multielectrode Mapping and Subsurface Near-Infrared Optical Mapping During Human Atrial Fibrillation
2020 · Aleksei Mikhailov, Brian Hansen, et al. · Circulation
Abstract 14900: Human Atrial Fibrillation Drivers Revealed by Machine Learning Using Multicomponent Electrograms and 3D CE-MRI Structural Features
2020 · Aleksei Mikhailov, Brian Hansen, et al. · Circulation
Works count: 17
Citation count: 16
H-index: 2
I10-index:
Year
Topic
Type